Literature DB >> 3055888

Cystic pancreatic tumors: CT and sonographic assessment.

C D Johnson1, D H Stephens, J W Charboneau, H A Carpenter, T J Welch.   

Abstract

Thirty-five CT scans and 23 sonograms of 45 pathologically proved pancreatic cystic neoplasms (16 microcystic adenomas, 17 mucinous [macrocystic] cystadenomas, and 12 mucinous [macrocystic] cystadenocarcinomas) in 43 patients were retrospectively and blindly reviewed. Radiologic findings and their usefulness in differentiating microcystic from mucinous subtypes were assessed. The number of cysts within the tumors (more than six in microcystic adenomas and six or fewer in mucinous cystadenomas and cystadenocarcinomas) and the diameter of the majority of cysts within the tumor (less than or equal to 2 cm in microcystic adenomas and greater than 2 cm in mucinous tumors) were the most helpful radiologic findings in differentiating tumor types. Calcification was present in 38% of microcystic adenomas, 18% of mucinous cystadenomas, and 8% of mucinous cystadenocarcinomas by CT. Calcification was not definitely identified on any of the sonograms. A central scar was identified in only two (13%) of 16 microcystic adenomas. Blind retrospective review was often able to correctly classify tumors as either microcystic (CT, 93%; sonography, 78%) or mucinous (CT, 95%; sonography, 93%). All tumors with a typical appearance on either CT or sonography were categorized correctly. Cystic pancreatic tumors may be difficult to prospectively separate from other types of pancreatic cysts. Assuming a cystic neoplasm is present, it often can be classified correctly as microcystic or mucinous (macrocystic) by using the above criteria.

Entities:  

Mesh:

Year:  1988        PMID: 3055888     DOI: 10.2214/ajr.151.6.1133

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  35 in total

1.  Cystic Neoplasms of the Pancreas.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-10

Review 2.  Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions.

Authors:  Michael G Sarr; Michel Murr; Thomas C Smyrk; Charles J Yeo; Carlos Fernandez-del-Castillo; Robert H Hawes; Patrick C Freeny
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

3.  Diagnosing cancer of the pancreas.

Authors:  J N Thompson
Journal:  BMJ       Date:  1990-10-06

4.  Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.

Authors:  Luca Barresi; Ilaria Tarantino; Antonino Granata; Gabriele Curcio; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

Review 5.  [Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors].

Authors:  M Fuchs; W Schepp
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

Review 6.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

7.  Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association.

Authors:  J Le Borgne; L de Calan; C Partensky
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 8.  Intraductal papillary-mucinous tumor and mucinous cystic neoplasm: CT and MR findings.

Authors:  Y Itai; M Minami
Journal:  Int J Gastrointest Cancer       Date:  2001

9.  Surgical treatment of incidentally identified pancreatic masses.

Authors:  Timothy L Fitzgerald; Andrew J Smith; Max Ryan; Mostafa Atri; Frances C Wright; Calvin H L Law; Sherif S Hanna
Journal:  Can J Surg       Date:  2003-12       Impact factor: 2.089

10.  The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects.

Authors:  C M Pyke; J A van Heerden; T V Colby; M G Sarr; A L Weaver
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.